Abstract:The CRISPR-Cas system holds great promise in the treatment of diseases caused by genetic variations. As wildtype SpyCas9 is known to generate many off-target effects, its use in the clinic remains controversial due to safety concerns. Several high-fidelity Cas9 variants with greater specificity have been developed using rational design and directed evolution. However, the enhancement of specificity by these methods is limited by factors like selection pressure and library diversity. Thus, in-silico protein engineering may provide a more efficient route for enhancing specificity, although computationally testing these proteins remains challenging. We recently demonstrated the advantage of normal mode analysis to simulate and predict the enzymatic function of SpyCas9 in the presence of mismatches. Here, we report several mathematical models describing the entropy and functionality relationships in the CRISPR-Cas9 system. We demonstrate the invariant characteristics of these models across different conformational structures. Based on these invariant models, we developed ComPE, a novel computational protein engineering method to modify the protein and measure the vibrational entropy of wildtype or variant SpyCas9 in complex with its sgRNA and target DNA. Using this platform, we discovered novel high-fidelity Cas9 variants with improved specificity. We functionally validated the improved specificity of four variants, and the intact on-target activity in one of them. Lastly, we demonstrate their reduced off-target editing and non-specific gRNA-independent DNA damage, highlighting their advantages for clinical applications. The described method could be applied to a wide range of proteins, from CRISPR-Cas orthologs to distinct proteins in any field where engineered proteins can improve biological processes.

High-throughput in vitro specificity profiling of natural and high-fidelity CRISPR-Cas9 variants

High-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention by improving specificity of the tools

Target-matched increased fidelity SpCas9 variants can edit any target without genome-wide off-target effects

Deleting Specific Residues From the HNH Linkers Creates A CRISPR-SpCas9 Variant With High Fidelity and Efficiency

A cleavage rule for selection of increased-fidelity SpCas9 variants with high efficiency and no detectable off-targets

Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage

Computationally Engineered CRISPR-SpyCas9 High-Fidelity Variants with Improved Specificity and Reduced Non-specific DNA Damage

Rationally engineered Cas9 nucleases with improved specificity

In Vitro Assay Revealed Mismatches Between Guide RNA and Target DNA Can Enhance Cas9 Nuclease Activity

Dynamics changes of CRISPR-Cas9 systems induced by high fidelity mutations.

In-depth assessment of the PAM compatibility and editing activities of Cas9 variants

Structural basis for mismatch surveillance by CRISPR–Cas9

A kinetic model predicts SpCas9 activity, improves off-target classification, and reveals the physical basis of targeting fidelity

Quantifying Protein-Nucleic Acid Interactions for Engineering Useful CRISPR-Cas9 Genome-Editing Variants

[The Development of SpCas9 Variants with High Specificity and Efficiency Based on the HH Theory]

Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage

Genome editing with natural and engineered CjCas9 orthologs

Mechanism of type II-B CRISPR-Cas9 enhanced specificity

Quantification of the affinities of CRISPR–Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences

Structural insights into a high fidelity variant of SpCas9

High-fidelity SaCas9 identified by directional screening in human cells